• Monthly
  • $25
  • $50
  • $100
  • $other
  • use PayPal

SPRING FUNDRAISER

Is it time for our Spring fundraiser already? If you enjoy what we offer, and have the means, please consider donating. The sooner we reach our modest goal, the faster we can get back to business as (un)usual. Please, stay safe and we’ll see you down the road.
FacebookTwitterRedditEmail

Clueless Pfizer Executives

On Thursday, November 30, Pfizer’s executives conducted a well rehearsed dog-and-pony show over at Pfizer’s research facilities in Groton, CT. All interest was focused on torcetrapib; the most important new drug in Pfizer’s pipeline, which boosts good cholesterol.

According to Forbes, Pfizer Chief Executive Jeffrey Kindler told about 250 analysts and investors attending the meeting that torcetrapib was “one of the most important developments in our generation.”

Pfizer research president John LaMattina said, “We believe this is the most important new development in cardiovascular medicine in years,” according to the Wall Street Journal.

On Saturday, December 2-two days later-Pfizer said in a statement that it is terminating all clinical tests of torcetrapib and its plans to bring the drug to market. A board of independent experts had reviewed the latest data from a 15,000-patient test on torcetrapib and found that patients on the drug were dying like flies; almost twice as many dead as on the comparator. The company also said it is asking doctors participating in studies of torcetrapib to tell patients to stop taking the drug immediately.

Associated Press concluded, “The news is devastating to Pfizer, which had been counting on the drug to revitalize stagnant sales that have been hurt by numerous patent expirations on key products. It has said it was spending around $800 million to develop torcetrapib.”

Of course, in the drug industry, bad stuff happens. But in this particular case, the whole scientific world had been worried about the fact that torcetrapib raises blood pressure. Not a good thing for a cardiovascular drug. But that didn’t stop the Pfizer executives from hyping torcetrapib. Until it turned out that “one of the most important developments in our generation” was really a killer drug-quite literally.

And this is what makes Pfizer’s CEO Mr. Kindler and Pfizer’s research chief Dr. LaMattina officially the most clueless executives in the drug business.

Peter Rost, M.D., is a former Vice President of Pfizer. He became well known in 2004 when he emerged as the first drug company executive to speak out in favor of reimportation of drugs. He is the author of “The Whistleblower, Confessions of a Healthcare Hitman.” See: http://the-whistleblower-by-peter-rost.blogspot.com/

 

 

More articles by:
May 28, 2020
Melvin Goodman
Trump’s War on Arms Control and Disarmament
Evaggelos Vallianatos
The Virtues of Not Eating Animals
Jeffrey St. Clair
Last Stand in the Big Woods
Jack Rasmus
Two Fictions of Mainstream Economics
Louisa Willcox
“What Are We Fighting About?” 9th Circuit Hears Yellowstone Grizzly Bear Delisting Case
Danny Sjursen
The Future of Forever War, American-Style
Steven Salaita
To Students and Teachers Targeted by the Israel Lobby
David Rosen
Silence=Death: Larry Kramer, RIP
Dean Baker
Restaurants in the Pandemic
Martin Billheimer
There is No Vacation Anymore
Jesse Jackson
It’s Time for Bold Responses to a Stark Crisis
Deborah Toler
Is Stacey Abrams Progressive?
Binoy Kampmark
Budget Cockups in the Time of Coronavirus
May 27, 2020
Ipek S. Burnett
The Irony of American Freedom 
Paul Street
Life in Hell: Online Teaching
Vijay Prashad
Why Iran’s Fuel Tankers for Venezuela Are Sending Shudders Through Washington
Lawrence Davidson
National Values: Reality or Propaganda?
Ramzy Baroud
Why Does Israel Celebrate Its Terrorists: Ben Uliel and the Murder of the Dawabsheh Family
Sam Pizzigati
The Inefficient and Incredibly Lucrative Coronavirus Vaccine Race
Mark Ashwill
Vietnam Criticized for Its First-Round Victory Over COVID-19
David Rovics
A Note from the Ministry of Staple Guns
Binoy Kampmark
One Rule for Me and Another for Everyone Else: The Cummings Coronavirus Factor
Nino Pagliccia
Canada’s Seat at the UN Security Council May be Coveted But is Far From a Sure Bet
Erik Molvar
Should Federal Public Lands be Prioritized for Renewable Energy Development?
R. G. Davis
Fascism: Is it Too Extreme a Label?
Gene Glickman
A Comradely Letter: What’s a Progressive to Do?
Jonathan Power
The Attacks on China Must Stop
John Kendall Hawkins
The Asian Pivot
May 26, 2020
Melvin Goodman
Trump Administration and the Washington Post: Picking Fights Together
John Kendall Hawkins
The Gods of Small Things
Patrick Cockburn
Governments are Using COVID-19 Crisis to Crush Free Speech
George Wuerthner
Greatest Good is to Preserve Forest Carbon
Thomas Klikauer – Nadine Campbell
The Covid-19 Conspiracies of German Neo-Nazis
Henry Giroux
Criminogenic Politics as a Form of Psychosis in the Age of Trump
John G. Russell
TRUMP-20: The Other Pandemic
John Feffer
Trump’s “Uncreative Destruction” of the US/China Relationship
John Laforge
First US Citizen Convicted for Protests at Nuclear Weapons Base in Germany
Ralph Nader
Donald Trump, Resign Now for America’s Sake: This is No Time for a Dangerous, Law-breaking, Bungling, Ignorant Ship Captain
James Fortin – Jeff Mackler
Killer Capitalism’s COVID-19 Back-to-Work Imperative
Binoy Kampmark
Patterns of Compromise: The EasyJet Data Breach
Howard Lisnoff
If a Covid-19 Vaccine is Discovered, It Will be a Boon to Military Recruiters
David Mattson
Grizzly Bears are Dying and That’s a Fact
Thomas Knapp
The Banality of Evil, COVID-19 Edition
May 25, 2020
Marshall Auerback
If the Federal Government Won’t Fund the States’ Emergency Needs, There is Another Solution
Michael Uhl
A Memory Fragment of the Vietnam War
FacebookTwitterRedditEmail